A case of autoimmune lymphoproliferative syndrome with a novel de novo FAS variant

References

• Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Updated understanding of autoimmune lymphoproliferative syndrome (ALPS). Clin Rev Allergy Immunol. 2016;50(1):55–63. doi:10.1007/s12016-015-8466-y.
   PubMed Web of Science ®Google Scholar
• Matson DR, Yang DT. Autoimmune lymphoproliferative syndrome an overview. Arch Pathol Lab Med. 2020;144(2):245–251. doi:10.5858/arpa.2018-0190-RS.
   PubMed Web of Science ®Google Scholar
• Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81(6):935–946. doi:10.1016/0092-8674(95)90013-6.
   PubMed Web of Science ®Google Scholar
• Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): Report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35–e40. doi:10.1182/blood-2010-04-280347.
   PubMed Web of Science ®Google Scholar
• Bleesing JJ, Nagaraj CB, Zhang K. Autoimmune lymphoproliferative syndrome. GeneReviews®. 2017; Published Online August 24 Accessed October 23, 2021. https://www.ncbi.nlm.nih.gov/books/NBK1108/
   Google Scholar
• Lim MS, Straus SE, Dale JK, et al. Pathological findings in human autoimmune lymphoproliferative syndrome. Am J Pathol. 1998;153(5):1541–1550. doi:10.1016/S0002-9440(10)65742-2.
   PubMed Web of Science ®Google Scholar
• Niss O, Sholl A, Bleesing JJ, Hildeman DA. IL-10/Janus kinase/signal transducer and activator of transcription 3 signaling dysregulates Bim expression in autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2015;135(3):762–770. doi:10.1016/j.jaci.2014.07.020.
   PubMed Web of Science ®Google Scholar
• Ikincioğullari A, Kendirli T, Doğu F, et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr. 2004;46(2):125–130. http://www.ncbi.nlm.nih.gov/pubmed/15214740
   PubMed Web of Science ®Google Scholar
• Aksu G, Genel F, Koturoğlu G, Kurugöl Z, Kütükçüler N. Serum immunoglobulin(IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr. 2005;47:19–24.
   PubMedGoogle Scholar
• Hughes H, Kahl L. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 21st ed. Philadelphia, PA: Elsevier; 2018.
   Google Scholar
• Schatorjé EJH, Gemen EFA, Driessen GJA, Leuvenink J, van Hout RWNM, de Vries E. Paediatric reference values for the peripheral T cell compartment. Scand J Immunol. 2012;75(4):436–444. doi:10.1111/J.1365-3083.2012.02671.X.
   PubMed Web of Science ®Google Scholar
• Eken A, Singh AK, Treuting PM, Oukka M. IL-23R + innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol. 2014;7(1):143–154. doi:10.1038/mi.2013.33.
   PubMed Web of Science ®Google Scholar
• Hafezi N, Zaki-Dizaji M, Nirouei M, et al. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review. Pediatr Allergy Immunol. 2021;32(7):1519–1532. doi:10.1111/pai.13535.
   PubMed Web of Science ®Google Scholar
• Patiroglu T, Gungor H, Unal E. Autoimmune diseases detected in children with primary immunodeficiency diseases: results from a reference centre at middle anatolia. Acta Microbiol Immunol Hung. 2012;59(3):343–353. doi:10.1556/AMICR.59.2012.3.5.
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat F, Magérus-Chatinet A, Neven B. The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol. 2018;38(5):558–568. doi:10.1007/s10875-018-0523-x.
   PubMed Web of Science ®Google Scholar
• Ben-Mustapha I, Agrebi N, Barbouche MR. Novel insights into FAS defects underlying autoimmune lymphoproliferative syndrome revealed by studies in consanguineous patients. J Leukoc Biol. 2018;103(3):501–508. doi:10.1002/JLB.5MR0817-332R.
   PubMed Web of Science ®Google Scholar
• Hsu AP, Dowdell KC, Davis J, et al. Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance. Genet Med. 2012;14(1):81–89. doi:10.1038/GIM.0B013E3182310B7D.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443. doi:10.1038/s41586-020-2308-7.
   PubMed Web of Science ®Google Scholar
• Karczewski KJ, Weisburd B, Thomas B, et al. The ExAC browser: displaying reference data information from over 60 000 exomes. Nucleic Acids Res. 2017;45(D1):D840–D845. doi:10.1093/nar/gkw971.
   PubMed Web of Science ®Google Scholar
• Sherry ST, Ward MH, Kholodov M, et al. DbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311. doi:10.1093/nar/29.1.308.
   PubMed Web of Science ®Google Scholar
• Martin FJ, Amode MR, Aneja A, et al. Ensembl 2023. Nucleic Acids Res. 2023;51(D1):D933–D941. doi:10.1093/nar/gkac958.
   PubMed Web of Science ®Google Scholar
• Kakadia PM, Van de Water N, Browett PJ, Bohlander SK. Efficient identification of somatic mutations in acute myeloid leukaemia using whole exome sequencing of fingernail derived DNA as germline control. Sci Rep. 2018;8(1):13751. doi:10.1038/s41598-018-31503-5.
   PubMedGoogle Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Bleesing JJH, Brown MR, Novicio C, et al. A composite picture of TcRα/β+ CD4–CD8-T cells (α/β-DNTCs) in humans with autoimmune lymphoproliferative syndrome. Clin Immunol. 2002;104(1):21–30. doi:10.1006/clim.2002.5225.
   PubMed Web of Science ®Google Scholar
• Allison A. Mechanisms of action of mycophenolate mofetil. Lupus. 2005;14 Suppl 1(3_suppl):s2–s8. doi:10.1191/0961203305lu2109oa.
   PubMedGoogle Scholar
• George LA, Teachey DT. Optimal management of autoimmune lymphoproliferative syndrome in children. Paediatr Drugs. 2016;18(4):261–272. doi:10.1007/s40272-016-0175-3.
   PubMed Web of Science ®Google Scholar